Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in PRA Health Sciences Inc (NASDAQ:PRAH) by 1.3% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,390 shares of the medical research company’s stock after buying an additional 129 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in PRA Health Sciences were worth $1,146,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Motco grew its holdings in shares of PRA Health Sciences by 937.0% in the first quarter. Motco now owns 280 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 253 shares during the period. Financial Gravity Wealth Inc. purchased a new stake in shares of PRA Health Sciences in the first quarter valued at about $53,000. CENTRAL TRUST Co grew its holdings in shares of PRA Health Sciences by 28.2% in the first quarter. CENTRAL TRUST Co now owns 842 shares of the medical research company’s stock valued at $93,000 after purchasing an additional 185 shares during the period. Enlightenment Research LLC purchased a new stake in shares of PRA Health Sciences in the fourth quarter valued at about $101,000. Finally, Carroll Financial Associates Inc. grew its holdings in shares of PRA Health Sciences by 7.6% in the first quarter. Carroll Financial Associates Inc. now owns 1,517 shares of the medical research company’s stock valued at $167,000 after purchasing an additional 107 shares during the period. Institutional investors and hedge funds own 98.14% of the company’s stock.

Shares of PRAH stock opened at $85.98 on Tuesday. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 0.97. The stock has a market cap of $5.65 billion, a price-to-earnings ratio of 21.88, a P/E/G ratio of 1.18 and a beta of 1.01. PRA Health Sciences Inc has a 1-year low of $80.28 and a 1-year high of $121.98.

PRA Health Sciences (NASDAQ:PRAH) last announced its earnings results on Wednesday, February 27th. The medical research company reported $1.21 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.18 by $0.03. The company had revenue of $729.65 million during the quarter, compared to analyst estimates of $750.67 million. PRA Health Sciences had a net margin of 5.50% and a return on equity of 26.87%. Equities research analysts anticipate that PRA Health Sciences Inc will post 4.63 earnings per share for the current fiscal year.

A number of equities research analysts recently issued reports on PRAH shares. Robert W. Baird upped their price objective on shares of PRA Health Sciences from $119.00 to $122.00 and gave the company an “outperform” rating in a report on Thursday, February 28th. BidaskClub lowered shares of PRA Health Sciences from a “hold” rating to a “sell” rating in a report on Friday, April 19th. Wolfe Research started coverage on shares of PRA Health Sciences in a report on Tuesday, April 2nd. They issued a “market perform” rating for the company. ValuEngine lowered shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, April 13th. Finally, SunTrust Banks upped their price objective on shares of PRA Health Sciences to $120.00 and gave the company an “average” rating in a report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. PRA Health Sciences presently has an average rating of “Hold” and a consensus target price of $113.22.

ILLEGAL ACTIVITY NOTICE: “Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires 129 Shares of PRA Health Sciences Inc (PRAH)” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/commonwealth-of-pennsylvania-public-school-empls-retrmt-sys-acquires-129-shares-of-pra-health-sciences-inc-prah/3017398.html.

PRA Health Sciences Profile

PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.

Recommended Story: What is the Ex-Dividend Date in Investing?

Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.